The news might have seemed to be pretty good the last time Boston Scientific (NYSE: BSX) reported its quarterly results. In April, the medical device maker announced that revenue rose 5% from the prior-year period while earnings increased by 8%. However, Boston Scientific missed Wall Street's estimates, which caused its stock to fall.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,